SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-000161
Filing Date
2022-01-03
Accepted
2022-01-03 16:21:57
Documents
2
Period of Report
2022-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3631
2 POA DOCUMENT poa.txt EX-24 3964
  Complete submission text file 0001209191-22-000161.txt   8970
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Issuer) CIK: 0001600847 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AKCEA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 9TH FLOOR BOSTON MA 02210
Business Address
Patterson Joshua F. (Reporting) CIK: 0001805702 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38716 | Film No.: 22502403